These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 18825752)
1. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Schreiner B; Bailey SL; Shin T; Chen L; Miller SD Eur J Immunol; 2008 Oct; 38(10):2706-17. PubMed ID: 18825752 [TBL] [Abstract][Full Text] [Related]
2. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Ortler S; Leder C; Mittelbronn M; Zozulya AL; Knolle PA; Chen L; Kroner A; Wiendl H Eur J Immunol; 2008 Jun; 38(6):1734-44. PubMed ID: 18421793 [TBL] [Abstract][Full Text] [Related]
3. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. Cheng X; Zhao Z; Ventura E; Gran B; Shindler KS; Rostami A J Neuroimmunol; 2007 Apr; 185(1-2):75-86. PubMed ID: 17320975 [TBL] [Abstract][Full Text] [Related]
4. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561 [TBL] [Abstract][Full Text] [Related]
5. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716 [TBL] [Abstract][Full Text] [Related]
6. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209 [TBL] [Abstract][Full Text] [Related]
7. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. Carter LL; Leach MW; Azoitei ML; Cui J; Pelker JW; Jussif J; Benoit S; Ireland G; Luxenberg D; Askew GR; Milarski KL; Groves C; Brown T; Carito BA; Percival K; Carreno BM; Collins M; Marusic S J Neuroimmunol; 2007 Jan; 182(1-2):124-34. PubMed ID: 17182110 [TBL] [Abstract][Full Text] [Related]
8. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960 [TBL] [Abstract][Full Text] [Related]
9. Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response. Seo SK; Seo HM; Jeong HY; Choi IW; Park YM; Yagita H; Chen L; Choi IH Immunol Lett; 2006 Feb; 102(2):222-8. PubMed ID: 16236366 [TBL] [Abstract][Full Text] [Related]
10. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals. Kim HK; Guan H; Zu G; Li H; Wu L; Feng X; Elmets C; Fu Y; Xu H J Leukoc Biol; 2006 Apr; 79(4):686-95. PubMed ID: 16461745 [TBL] [Abstract][Full Text] [Related]
11. Expression of programmed death 1 ligands by murine T cells and APC. Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930 [TBL] [Abstract][Full Text] [Related]
12. B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance. Waisman A; Yogev N Eur J Immunol; 2009 Jun; 39(6):1448-51. PubMed ID: 19499529 [TBL] [Abstract][Full Text] [Related]
13. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model. Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910 [TBL] [Abstract][Full Text] [Related]
14. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673 [TBL] [Abstract][Full Text] [Related]
15. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. Duncan DS; Miller SD PLoS One; 2011 Apr; 6(4):e18548. PubMed ID: 21494618 [TBL] [Abstract][Full Text] [Related]
16. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Latchman YE; Liang SC; Wu Y; Chernova T; Sobel RA; Klemm M; Kuchroo VK; Freeman GJ; Sharpe AH Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10691-6. PubMed ID: 15249675 [TBL] [Abstract][Full Text] [Related]
17. Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis. Ren Y; Lu L; Guo TB; Qiu J; Yang Y; Liu A; Zhang JZ J Immunol; 2008 Jul; 181(2):1491-8. PubMed ID: 18606704 [TBL] [Abstract][Full Text] [Related]
18. B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells. Brandl C; Ortler S; Herrmann T; Cardell S; Lutz MB; Wiendl H PLoS One; 2010 May; 5(5):e10800. PubMed ID: 20520738 [TBL] [Abstract][Full Text] [Related]